FDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, Transplantation
ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluationMay 2, 2019Head & Neck/Thyroid Cancers
CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
SRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung Cancer
Idelalisib shows long-term safety, efficacy for relapsed CLLApril 26, 2019Leukemia, Myelodysplasia, TransplantationHematology
High-dose MTX-based chemo is well tolerated in older PCNSL patientsApril 24, 2019Lymphoma & Plasma Cell Disorders
Monitoring, early intervention key to CAR T safetyApril 24, 2019Lymphoma & Plasma Cell DisordersHematology
